Our data suggested that PKM2 may channel glucose intermediates (glucose-6-phosphate) to the pentose phosphate shunt which produces NADPH to reduce the level of ROS in the cells, therefore further conferring a growth advantage to HCC cells. Here, PKM is linked to hepatocellular carcinoma.